https://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svg00Wendy Kennedyhttps://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svgWendy Kennedy2025-03-28 14:17:152025-03-28 14:28:50Causal mutations in the genes encoding Kv3.1 and Kv3.2 have been increasingly linked to debilitating CNS diseases such as epilepsy, developmental encephalopathies, intellectual disability and autism
https://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svg00Wendy Kennedyhttps://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svgWendy Kennedy2025-03-28 14:07:222025-03-28 14:29:48Kv3 Modulator AUT00206 offers potential as a precision medicine approach for the treatment of progressive myoclonic epilepsy (EPM7)